Melatonin has become a familiar ingredient in the sleep-support category. But as interest grows in plant-based alternatives, an important question emerges: Can an ingredient that supports the body’s natural sleep-regulating processes deliver meaningful benefits comparable to supplemental melatonin?
New clinical research involving ThymoDream™, a patented black cumin seed oil (Nigella sativa) from Akay Bioactives, offers an intriguing perspective.
Putting plant-based sleep support to the test
In a randomised, double-blind, active-controlled crossover study featured in Frontiers in Sleep, researchers evaluated ThymoDream against synthetic melatonin in 24 healthy adults reporting sleep disturbances.
Participants received either 200 mg of ThymoDream or 5 mg of melatonin nightly.
Researchers assessed multiple dimensions of sleep, including sleep duration, sleep efficiency, time to fall asleep, nighttime awakenings, and daytime sleepiness.
After seven days, ThymoDream supplementation was associated with a 12.6% improvement in sleep efficiency, an 8.1% increase in total sleep time, a 33.2% reduction in sleep latency, and a 34.8% reduction in wake after sleep onset.
Both interventions demonstrated benefits, but their relative strengths differed. ThymoDream produced a significantly greater increase in total sleep time, while melatonin delivered a greater reduction in the time required to fall asleep. Differences in sleep efficiency and wake after sleep onset were not statistically significant between treatments.
The daytime difference
Perhaps the most compelling finding extended beyond the nighttime hours.
Among participants with elevated daytime sleepiness at baseline, ThymoDream reduced Epworth Sleepiness Scale scores by 25.7% after seven days. Melatonin produced a smaller, statistically non-significant reduction of approximately 3%. At study end, daytime sleepiness scores were 20.6% lower with ThymoDream than with melatonin.
For formulators, this finding introduces an important consideration: sleep support isn’t solely about what happens overnight, but also how consumers feel the following day.
Working with the body’s natural rhythms
The research also explored physiological markers involved in sleep regulation.
ThymoDream supplementation supported a 2- to 2.9-fold increase in natural melatonin levels for up to six hours. After seven days, researchers also observed an approximately 90-minute advance in dim light melatonin onset, a marker of circadian timing, alongside a 21.4% reduction in cortisol.
These findings suggest a differentiated approach to sleep support, one centred on influencing the body’s endogenous sleep-regulating processes rather than supplying melatonin directly.
For an industry increasingly interested in plant-based innovation, the study offers a promising direction. While larger studies are needed to confirm these findings, ThymoDream’s head-to-head results highlight opportunities to formulate for multiple dimensions of sleep, including duration, quality, and daytime alertness.
Reference: Harshith CS, Jestin TV, Syam DS, Prathibha P, Allimuthu N, Abhirami N, Radhika A, Krishnakumar IM and Plakkal Ayyappan J (2026) Responsiveness of ThymoDream® as a natural modulator of the circadian axis: a comparative RCT with melatonin supplementation employing melatonin profiling and actigraphy. Front. Sleep 5:1879110. doi: 10.3389/frsle.2026.1879110
